Daniel McGowan

Scientist, writer, adventurer, philosopher

[The Science of Parkinson's @ScienceofPD]

SIRT3 is negatively correlated with age & phosphorylated Ser129 α-synuclein in human postmortem brains (#Parkinsons vs controls); In rats, a-synuclein pre-formed fibrils = neurodegeneration, but over-expression of SIRT3 reduces this
https://t.co/J47UCJIsjH

[Cure Parkinson's NZ @Cure_Parkies_NZ]

It's personal. This is who we are.

https://t.co/aNoKrIys7M

#parkinsons #parkinsonsdisease #parkinsonsawareness #hereforacure

[Cure Parkinson's NZ @Cure_Parkies_NZ]

Did you know that April is Parkinson's Awareness Month? Or that April 11 is World Parkinson's Day? Get in touch if you'd like to know more or help someone with this condition.
#ParkinsonsDisease #parkinsondisease #parkinsonsawareness #parkinsons #findacure #CureParkinsons

[Daniel McGowan @dpmcg75]

Nice to see this trial getting started, especially after the promising phase 2 trial results. Congratulations to our friends at Cure Parkinson's and Van Andel Institute.

https://t.co/sca8NHkuEb

[Daniel McGowan @dpmcg75]

Nice to see this trial getting started, especially after the promising phase 2 trial results. Congratulations to our friends at Cure Parkinson's and Van Andel Institute.

https://t.co/sca8NHkuEb

[Cure Parkinson's NZ @Cure_Parkies_NZ]

And they're off! Let the pain begin. Good luck boys - at Cure Parkinson's NZ we really appreciate your fabulous fundraising efforts. See you at the finish! #fundraising #coasttocoast #coasttocoastchallenge #parkinsonsdisease #parkinsons #parkinson #findacure

[Cure Parkinson's NZ @Cure_Parkies_NZ]

Only a week now until Rob (left) and Sam (right) start their two-day Coast to Coast challenge raising much-needed funds for Parkinson's research. There's still time to help these guys reach their fundraising target at: https://t.co/GangT7WGhN

Please show your support.

[Edanz @edanzscience]

Great to work together @EASEeditors
https://t.co/fVkF66Yy6T

#AcWri #AcademicChatter #AcademicTwitter

[Edanz @edanzscience]

What r u doing Friday 9am (UK)?
➡️ https://t.co/I9mZFgAfip 🔔

#AcademicTwitter #courses #academicwriting #phdstudent #phdforum #phdlife @AcademicChatter
#scicomm #phdchat #academicpublishing #Past3amSquad @phdforum @timeshighered
@PhDLife7 @PhDchatter

[Kevin J. Fowler Principal The Voice of the Patient @gratefull080504]

The fact that DAPA had an effect with #ckd patients without #diabetes truly meets the definition of #gamechanger #DAPACKD #Dapagliflozin I also look forward to trials in #kidneytransplant recipients #ESCCongress

[Henry Han @HanCardiomd]

LV EF 60 is new for women and 55 for men . Is 60 the new 40? #ESCCongress @mirvatalasnag @JGrapsa @SolovevaAnzhela @AndrewJSauer @SolovevaAnzhela @hvanspall @ALEX_MISCHIE @ValleAlfonso @DrSarahClarke @saramoscatelli7 @JSabatino86 @MihaiTrofenciuc @HFA_President

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

Dr. Morris @ACCinTouch presenting #ESCCongress on Lifestyle changes for CVD Prevention: "A little Less Drugs, a Few Move Vegetables, and a lot more Rock & Roll"
🔺Impact of Lifestyle cannot be overstated
🔺 Shared decision making is key in all our management
🔺Lifestyle Rx needed

[Javier Torres @JTLLERGO]

EMPEROR reduced: Empagliflozine
‼️ ⬇️ 25% CV death or HHF (regardless of the presence or absence of diabetes)
‼️⬇️ 30% HHF
‼️Annual rate of decline in GFR rate was slower (–0.55 vs. –2.28 ml per minute)
https://t.co/9vPR6a5A9G
#ESCCongress @secardiologia

[Enrique Santas @SantasEnrique]

Big news from #ESCCongress!!

EMPEROR-Reduced: Empagliflozin vs placebo in #heartfailure with reduced ejection fraction

✔️ 25% ⤵️ in primary endpoint (CV death/ HF 🏥)
✔️ 30% ⤵️ in HF 🏥
✔️ 50% ⤵️ in renal endpoints

[Daniel McGowan @dpmcg75]

Thank you @DrJinRussell for being a voice of reason

[Jin Russell @DrJinRussell]

In my last set of tweets on @MatthewHootonNZ's armchair epidemiological reckons, I emphasised that he does not have the skills to analyse epidemiological data.

In his latest Herald piece, he unfortunately makes rookie mistakes again /1

[Edanz @edanzscience]

Lilly Gray (ELS CMPP) gives you tips on writing a strong Discussion section to explain how your study contributes to your field.
#IMRaD #manuscript #writing
https://t.co/okpd6xGx3H

[21st Century City @urbanthoughts11]

“A developed country is not a place where the poor have cars. It’s where the rich use public transportation.”
via @mroich

[Edanz @edanzscience]

If you are reading or conducting systematic reviews, you need to know how all the parts fit together. Sign into Learning Lab now for FREE to see a visual dissection of a real review!
#review #meta-analysis
https://t.co/813Ki1loHU

[Daniel McGowan @dpmcg75]

We love our SLRs... pinnacle of the evidence pyramid!

[Edanz @edanzscience]

Publishing an amazing systematic review may get you a new job or finally convince your department to let you graduate. Terrific! But what do you do now?
#research #preparation #systematic #review
https://t.co/Sxr6g8nj0t

[Edanz @edanzscience]

If you are reading or conducting systematic reviews, you need to know how all the parts fit together. Sign into Learning Lab now for FREE to see a visual dissection of a real review!
#review #meta-analysis
https://t.co/wnC8hdoyfM